Pfizer Inc., a biopharmaceutical firm, reported that Emblaveo (aztreonam-avibactam) has received marketing approval from the European Commission (EC) for the treatment of adult patients with pyelonephritis, hospital-acquired pneumonia (HAP)...
Ipsen, a worldwide biopharmaceutical organization, announced a worldwide collaboration with Skyhawk Therapeutics, a clinical-stage biopharmaceutical organization, to find and foster novel little particles that tweak RNA for intriguing neurological...
In a deal worth up to $380 million in upfront and milestone payments, Bristol Myers Squibb and Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing...
Light Pharma Inc, a biotechnology company creating designated and extraordinary cancer treatments utilizing its restrictive RADR® artificial intelligence and AI ("ML") stage with various clinical-stage drug programs, reported today that the...
The pharmaceutical company Eli Lilly announced in a new tab that it will acquire Nexus Pharmaceuticals' manufacturing facility to produce injectable medicines. The firm expects creation at the office situated in Charming Grassland, Wisconsin...
Zydus Lifesciences, an India-based pharmaceutical company, announced the availability of a generic treatment for overactive bladder in the US market. Zydus stated in a regulatory filing that the company has launched Mirabegron extended-release...
.jpg)
